Cargando…

Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus–Exposed, Uninfected Infants

BACKGROUND: Prophylactic cotrimoxazole treatment is recommended in human immunodeficiency virus (HIV)–exposed, uninfected (HEU) infants, but the effects of this treatment on developing HEU infant gut microbiotas and resistomes are largely undefined. METHODS: We analyzed whole-metagenome sequencing d...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Souza, Alaric W, Moodley-Govender, Eshia, Berla, Bertram, Kelkar, Tejas, Wang, Bin, Sun, Xiaoqing, Daniels, Brodie, Coutsoudis, Anna, Trehan, Indi, Dantas, Gautam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778358/
https://www.ncbi.nlm.nih.gov/pubmed/31832638
http://dx.doi.org/10.1093/cid/ciz1186
_version_ 1783631111373455360
author D’Souza, Alaric W
Moodley-Govender, Eshia
Berla, Bertram
Kelkar, Tejas
Wang, Bin
Sun, Xiaoqing
Daniels, Brodie
Coutsoudis, Anna
Trehan, Indi
Dantas, Gautam
author_facet D’Souza, Alaric W
Moodley-Govender, Eshia
Berla, Bertram
Kelkar, Tejas
Wang, Bin
Sun, Xiaoqing
Daniels, Brodie
Coutsoudis, Anna
Trehan, Indi
Dantas, Gautam
author_sort D’Souza, Alaric W
collection PubMed
description BACKGROUND: Prophylactic cotrimoxazole treatment is recommended in human immunodeficiency virus (HIV)–exposed, uninfected (HEU) infants, but the effects of this treatment on developing HEU infant gut microbiotas and resistomes are largely undefined. METHODS: We analyzed whole-metagenome sequencing data from 163 longitudinally collected stool samples from 63 HEU infants randomized to receive (n = 34; CTX-T) or to not receive (n = 29; CTX-N) prophylactic cotrimoxazole treatment. We generated taxonomic, functional pathway, and resistance gene profiles for each sample and compared microbiome signatures between the CTX-T and CTX-N infants. RESULTS: Metagenomic analysis did not reveal significant differences in taxonomic or functional pathway α-diversity between CTX-T and CTX-N infants. In contrast, resistance gene prevalence (P = .00719) and α-diversity (P = .0045) increased in CTX-T infants. These differences increased over time for both resistance gene prevalence measured by log-normalized abundance (4-month mean, 0.71 [95% confidence interval {CI}, .2–1.2] and 6-month mean, 0.85 [95% CI, .1–1.7]) and α-diversity (P = .0045). Unlike α-diversity, interindividual gut microbiome taxonomic (mean, −0.11 [95% CI, −.15 to −.077]), functional taxonomic (mean, −0.050 [95% CI, −.084 to −.017]), and resistance gene (mean, −0.13 [95% CI, −.17 to −.099]) β-diversity decreased in CTX-T infants compared with CTX-N infants. These results are consistent with persistent antibiotic selection pressure. CONCLUSIONS: Cotrimoxazole prophylaxis in HEU infants decreased gut microbiome β-diversity and increased antibiotic resistance gene α-diversity and prevalence. Antibiotic resistance is a growing threat, especially in low- and middle-income countries where the higher perinatal HIV exposure rates result in cotrimoxazole prophylaxis. Understanding effects from current HEU infant antibiotic prophylaxis guidelines will inform guideline revisions and efforts to reduce increasing antibiotic resistance.
format Online
Article
Text
id pubmed-7778358
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77783582021-01-07 Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus–Exposed, Uninfected Infants D’Souza, Alaric W Moodley-Govender, Eshia Berla, Bertram Kelkar, Tejas Wang, Bin Sun, Xiaoqing Daniels, Brodie Coutsoudis, Anna Trehan, Indi Dantas, Gautam Clin Infect Dis Major Articles and Commentaries BACKGROUND: Prophylactic cotrimoxazole treatment is recommended in human immunodeficiency virus (HIV)–exposed, uninfected (HEU) infants, but the effects of this treatment on developing HEU infant gut microbiotas and resistomes are largely undefined. METHODS: We analyzed whole-metagenome sequencing data from 163 longitudinally collected stool samples from 63 HEU infants randomized to receive (n = 34; CTX-T) or to not receive (n = 29; CTX-N) prophylactic cotrimoxazole treatment. We generated taxonomic, functional pathway, and resistance gene profiles for each sample and compared microbiome signatures between the CTX-T and CTX-N infants. RESULTS: Metagenomic analysis did not reveal significant differences in taxonomic or functional pathway α-diversity between CTX-T and CTX-N infants. In contrast, resistance gene prevalence (P = .00719) and α-diversity (P = .0045) increased in CTX-T infants. These differences increased over time for both resistance gene prevalence measured by log-normalized abundance (4-month mean, 0.71 [95% confidence interval {CI}, .2–1.2] and 6-month mean, 0.85 [95% CI, .1–1.7]) and α-diversity (P = .0045). Unlike α-diversity, interindividual gut microbiome taxonomic (mean, −0.11 [95% CI, −.15 to −.077]), functional taxonomic (mean, −0.050 [95% CI, −.084 to −.017]), and resistance gene (mean, −0.13 [95% CI, −.17 to −.099]) β-diversity decreased in CTX-T infants compared with CTX-N infants. These results are consistent with persistent antibiotic selection pressure. CONCLUSIONS: Cotrimoxazole prophylaxis in HEU infants decreased gut microbiome β-diversity and increased antibiotic resistance gene α-diversity and prevalence. Antibiotic resistance is a growing threat, especially in low- and middle-income countries where the higher perinatal HIV exposure rates result in cotrimoxazole prophylaxis. Understanding effects from current HEU infant antibiotic prophylaxis guidelines will inform guideline revisions and efforts to reduce increasing antibiotic resistance. Oxford University Press 2019-12-13 /pmc/articles/PMC7778358/ /pubmed/31832638 http://dx.doi.org/10.1093/cid/ciz1186 Text en © The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Major Articles and Commentaries
D’Souza, Alaric W
Moodley-Govender, Eshia
Berla, Bertram
Kelkar, Tejas
Wang, Bin
Sun, Xiaoqing
Daniels, Brodie
Coutsoudis, Anna
Trehan, Indi
Dantas, Gautam
Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus–Exposed, Uninfected Infants
title Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus–Exposed, Uninfected Infants
title_full Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus–Exposed, Uninfected Infants
title_fullStr Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus–Exposed, Uninfected Infants
title_full_unstemmed Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus–Exposed, Uninfected Infants
title_short Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus–Exposed, Uninfected Infants
title_sort cotrimoxazole prophylaxis increases resistance gene prevalence and α-diversity but decreases β-diversity in the gut microbiome of human immunodeficiency virus–exposed, uninfected infants
topic Major Articles and Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778358/
https://www.ncbi.nlm.nih.gov/pubmed/31832638
http://dx.doi.org/10.1093/cid/ciz1186
work_keys_str_mv AT dsouzaalaricw cotrimoxazoleprophylaxisincreasesresistancegeneprevalenceandadiversitybutdecreasesbdiversityinthegutmicrobiomeofhumanimmunodeficiencyvirusexposeduninfectedinfants
AT moodleygovendereshia cotrimoxazoleprophylaxisincreasesresistancegeneprevalenceandadiversitybutdecreasesbdiversityinthegutmicrobiomeofhumanimmunodeficiencyvirusexposeduninfectedinfants
AT berlabertram cotrimoxazoleprophylaxisincreasesresistancegeneprevalenceandadiversitybutdecreasesbdiversityinthegutmicrobiomeofhumanimmunodeficiencyvirusexposeduninfectedinfants
AT kelkartejas cotrimoxazoleprophylaxisincreasesresistancegeneprevalenceandadiversitybutdecreasesbdiversityinthegutmicrobiomeofhumanimmunodeficiencyvirusexposeduninfectedinfants
AT wangbin cotrimoxazoleprophylaxisincreasesresistancegeneprevalenceandadiversitybutdecreasesbdiversityinthegutmicrobiomeofhumanimmunodeficiencyvirusexposeduninfectedinfants
AT sunxiaoqing cotrimoxazoleprophylaxisincreasesresistancegeneprevalenceandadiversitybutdecreasesbdiversityinthegutmicrobiomeofhumanimmunodeficiencyvirusexposeduninfectedinfants
AT danielsbrodie cotrimoxazoleprophylaxisincreasesresistancegeneprevalenceandadiversitybutdecreasesbdiversityinthegutmicrobiomeofhumanimmunodeficiencyvirusexposeduninfectedinfants
AT coutsoudisanna cotrimoxazoleprophylaxisincreasesresistancegeneprevalenceandadiversitybutdecreasesbdiversityinthegutmicrobiomeofhumanimmunodeficiencyvirusexposeduninfectedinfants
AT trehanindi cotrimoxazoleprophylaxisincreasesresistancegeneprevalenceandadiversitybutdecreasesbdiversityinthegutmicrobiomeofhumanimmunodeficiencyvirusexposeduninfectedinfants
AT dantasgautam cotrimoxazoleprophylaxisincreasesresistancegeneprevalenceandadiversitybutdecreasesbdiversityinthegutmicrobiomeofhumanimmunodeficiencyvirusexposeduninfectedinfants